Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3176851000168110 | insulin aspart 30 international units / 1 mL + insulin aspart protamine 70 international units / 1 mL injection, 5 x 3 mL pen devices (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3176861000168112 | insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, 5 x 3 mL pen devices | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, 5 x 3 mL pen devices | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, 5 x 3 mL pen devices | has MPUU | insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL pen device | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Novomix 30 Flexpen injection, 5 x 3 mL pen devices | Is a | True | insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, 5 x 3 mL pen devices | Inferred relationship | Some |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product pack reference set
FHIR